ES2040715T3 - Derivados de pirimidina, su fabricacion y los medicamentos que los contienen. - Google Patents

Derivados de pirimidina, su fabricacion y los medicamentos que los contienen.

Info

Publication number
ES2040715T3
ES2040715T3 ES198787111280T ES87111280T ES2040715T3 ES 2040715 T3 ES2040715 T3 ES 2040715T3 ES 198787111280 T ES198787111280 T ES 198787111280T ES 87111280 T ES87111280 T ES 87111280T ES 2040715 T3 ES2040715 T3 ES 2040715T3
Authority
ES
Spain
Prior art keywords
hydrogen
alkyl
oxygen
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787111280T
Other languages
English (en)
Inventor
Robert Wilson Lambert
Joseph Armstrong Martin
Gareth John Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620070A external-priority patent/GB8620070D0/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2040715T3 publication Critical patent/ES2040715T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LOS COMPUESTOS DE FORMULA GENERAL (I), Y SUS TAUTOMEROS TIENEN PROPIEDADES ANTIVIRIASICAS. EN LA FORMULA (I) R1 REPRESENTA UN HALOGENO, UN ALQUILO C1-C4, HALO-(ALQUILO C1-C4) O ALCANOILO- C2-4, R2 HIDROGENO, HIDROXI, ALCOXI C1-4, TIOALQUILOC1-4 O FENIL-(ALCOXI C1-4), O EN EL CASO DE QUE X SEA OXIGENO TAMBIEN PUEDE SER ACILOXI, R3 ES HIDROGENO O ALQUILO C1-4, R4 ES UN GRUPO CARBOCICLICO O HETEROCICLICO, R5 ES HIDROGENO O FLUOR, M = 0,1 O 2, X OXIGENO O NH, Y UNA UNION DIRECTA -CH=CH-, -C=C O UN GRUPO DE FORMULA (Z)N-A- (A) EN LA QUE A ES UN GRUPO ALQUILENO C1-8, QUE PUEDE ESTAR SUSTITUIDO POR UNO O DOS GRUPOS FENILO, Z SIGNIFICA OXIGENO, AZUFRE, SO O SO2 Y N SIGNIFICA 0 O 1, CON LA CONDICION DE QUE R1 SEA DIFERENTE DE (I), CUANDO R2 REPRESENTA HIDROGENO, HIDROXI O BENZOILOXI, R3 HIDROGENO, R4 FENILO NO SUSTITUIDO, R5 HIDROGENO, M, O, X, AZUFRE E Y UN ENLACE DIRECTO. SE PREPARAN POR METODOS CONOCIDOS Y USUALES.
ES198787111280T 1986-08-18 1987-08-04 Derivados de pirimidina, su fabricacion y los medicamentos que los contienen. Expired - Lifetime ES2040715T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868620070A GB8620070D0 (en) 1986-08-18 1986-08-18 Pyrimidine derivatives
GB878711336A GB8711336D0 (en) 1986-08-18 1987-05-14 Pyrimidine derivatives

Publications (1)

Publication Number Publication Date
ES2040715T3 true ES2040715T3 (es) 1993-11-01

Family

ID=26291195

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787111280T Expired - Lifetime ES2040715T3 (es) 1986-08-18 1987-08-04 Derivados de pirimidina, su fabricacion y los medicamentos que los contienen.

Country Status (22)

Country Link
US (2) US4851519A (es)
EP (1) EP0257378B1 (es)
JP (1) JPH0794453B2 (es)
CN (1) CN1020106C (es)
AU (1) AU602909B2 (es)
CA (1) CA1303031C (es)
CS (1) CS272225B2 (es)
DE (1) DE3771146D1 (es)
DK (1) DK375787A (es)
ES (1) ES2040715T3 (es)
FI (1) FI86639C (es)
GR (1) GR3002636T3 (es)
HU (1) HU199500B (es)
IE (1) IE61061B1 (es)
IL (1) IL83509A (es)
MC (1) MC1846A1 (es)
MX (1) MX174238B (es)
NO (1) NO170884C (es)
NZ (1) NZ221412A (es)
PH (1) PH24653A (es)
PT (1) PT85551B (es)
ZW (1) ZW14187A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK163128C (da) * 1986-08-12 1992-06-15 Hoffmann La Roche Pyrimidinnucleosider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende pyrimidinnucleosiderne og anvendelse af pyrimidinnucleosiderne
NO170884C (no) * 1986-08-18 1992-12-23 Hoffmann La Roche Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
US5312961A (en) * 1989-02-14 1994-05-17 Elf Sanofi 2-amino-7-hydroxytetralin carboxylalkyl ethers
EP0668290B1 (en) * 1990-02-28 1998-11-11 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
US5652335A (en) * 1990-02-28 1997-07-29 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
US5306722A (en) * 1992-09-02 1994-04-26 Bristol-Myers Squibb Company Thymidine derivatives and therapeutic method of use
US6040298A (en) * 1992-12-23 2000-03-21 Oclassen Pharmaceuticals, Inc. Methods for treatment with compositions effective against acyclovir-resistant strains of herpes viruses
GB9514268D0 (en) * 1995-07-13 1995-09-13 Hoffmann La Roche Pyrimidine nucleoside
GB9606264D0 (en) * 1995-07-13 1996-05-29 Hoffmann La Roche Pyrimidine nucleoside derivatives
GB9608199D0 (en) * 1995-08-04 1996-06-26 Hoffmann La Roche Pyrimide nucleoside derivatives
US5783689A (en) * 1996-11-12 1998-07-21 University Of Notre Dame Antibacterial and antifungal nucleosides
CA2579756C (en) * 2004-06-19 2013-04-30 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
US7629447B2 (en) * 2006-09-12 2009-12-08 Wako Pure Chemical Industries, Ltd. Dideoxynucleoside derivatives
JP5205873B2 (ja) * 2006-09-12 2013-06-05 和光純薬工業株式会社 新規なジデオキシヌクレオシド誘導体
EP2459231B1 (de) * 2009-07-31 2016-06-08 Ethris Gmbh Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression
DE102013225401A1 (de) 2013-12-10 2015-06-11 BSH Hausgeräte GmbH Haushaltsgerät mit einer in einen Verstauraum einfahrbaren Tür und Verfahren zum öffnen und Schließen einer Tür eines Haushaltsgeräts
DE102013225402A1 (de) 2013-12-10 2015-06-11 BSH Hausgeräte GmbH Haushaltsgerät mit einer in einem Stauraum versenkbaren Tür und verschiebbarer Drehachse einer Lagereinheit sowie Verfahren zum öffnen und Schließen einer derartigen Tür
DE102013225403A1 (de) 2013-12-10 2015-06-11 BSH Hausgeräte GmbH Haushaltsgerät mit einer in einem Verstauraum versenkbaren Tür mit vertikaler Lageveränderungsmöglichkeit einer Drehachse einer Lagereinheit sowie Verfahren zum öffnen und Schließen einer Tür
DE102015206577A1 (de) 2015-04-13 2016-10-13 BSH Hausgeräte GmbH Haushaltsgerät mit einer in einem Verstauraum versenkbaren Tür mit elliptischer Kulisse zur Bewegung eines Lagerbügels einer Tür-Lagereinheit
DE102015206576A1 (de) 2015-04-13 2016-10-13 BSH Hausgeräte GmbH Haushaltsgerät mit einer in einem Verstauraum versenkbaren Tür mit spezifischer Lagereinheit
EP3307262B1 (en) 2015-06-15 2021-05-19 NMD Pharma A/S Compounds for use in treating neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
DE102018201949A1 (de) 2018-02-08 2019-08-08 BSH Hausgeräte GmbH Gargerät mit einer in einen Verstauraum versenkbaren Tür mit einem spezifischen Koppelmodul, sowie Verfahren zum Bewegen einer Tür
DE102018201950A1 (de) 2018-02-08 2019-08-08 BSH Hausgeräte GmbH Gargerät mit einem Technikteil für eine versenkbare Tür, welches eine Führungsbahn in einer oberen Höhenhälfte des Technikteils aufweist

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128639A (en) * 1977-12-14 1978-12-05 Research Corporation Nitrosourea analogs of thymidine
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
DE3045342A1 (de) * 1980-12-02 1982-07-01 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Neue substituierte pyrimidin-nukleoside mit antiviraler und cytostatischer wirkung, verfahren zu deren herstellung und daraus bereitete arzneiformen
DE3045375A1 (de) * 1980-12-02 1982-07-01 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Neue substituierte pyrimidin-nukleoside mit antiviraler wirkung, verfahren zu deren herstellung und daraus zubereitete arzneiformen
US4762823A (en) * 1985-10-16 1988-08-09 Sloan-Kettering Institute For Cancer Research Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil
DK363987A (da) * 1986-08-08 1988-02-09 Hoffmann La Roche Pyrimidinderivater
DK163128C (da) * 1986-08-12 1992-06-15 Hoffmann La Roche Pyrimidinnucleosider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende pyrimidinnucleosiderne og anvendelse af pyrimidinnucleosiderne
NO170884C (no) * 1986-08-18 1992-12-23 Hoffmann La Roche Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater

Also Published As

Publication number Publication date
EP0257378B1 (de) 1991-07-03
FI873555A (fi) 1988-02-19
DK375787D0 (da) 1987-07-17
NO872961L (no) 1988-02-19
CA1303031C (en) 1992-06-09
ZW14187A1 (en) 1988-02-24
DE3771146D1 (de) 1991-08-08
DK375787A (da) 1988-02-19
NO170884B (no) 1992-09-14
NO872961D0 (no) 1987-07-15
MC1846A1 (fr) 1988-09-30
PT85551B (pt) 1990-05-31
FI873555A0 (fi) 1987-08-17
EP0257378A1 (de) 1988-03-02
IL83509A0 (en) 1988-01-31
IE872191L (en) 1988-02-18
CS583487A2 (en) 1990-03-14
MX7769A (es) 1993-11-01
NZ221412A (en) 1990-11-27
PT85551A (en) 1987-09-01
IE61061B1 (en) 1994-09-21
NO170884C (no) 1992-12-23
GR3002636T3 (en) 1993-01-25
FI86639C (fi) 1992-09-25
US4851519A (en) 1989-07-25
IL83509A (en) 1994-05-30
HUT45544A (en) 1988-07-28
CN1020106C (zh) 1993-03-17
MX174238B (es) 1994-05-02
AU7684187A (en) 1988-02-25
FI86639B (fi) 1992-06-15
PH24653A (en) 1990-09-07
CS272225B2 (en) 1991-01-15
JPH0794453B2 (ja) 1995-10-11
AU602909B2 (en) 1990-11-01
HU199500B (en) 1990-02-28
CN87105758A (zh) 1988-03-02
JPS6351384A (ja) 1988-03-04
US5010060A (en) 1991-04-23

Similar Documents

Publication Publication Date Title
ES2040715T3 (es) Derivados de pirimidina, su fabricacion y los medicamentos que los contienen.
DK148484D0 (da) Guanidin-derivater
ES8800250A1 (es) Procedimiento para preparar acidos propano-fosfonosos susti-tuidos
ATE67232T1 (de) Stabilisierte galaktomannangummizusammensetzungen.
AR246739A1 (es) Procedimiento para preparar derivados de tienoimidazol sustituidos.
DK680887A (da) Quinolinforbindelse og farmaceutiske praeparater med indhold af en saadan forbindelse
ES2061580T3 (es) Compuestos de 3,7-diazabiciclo(3,3,1)nonano, asi como procedimiento para su preparacion y medicamentos que contienen estos compuestos.
BR8501113A (pt) Derivados de i-hidroxi-pirazol inibidores de nitrificacao
ES2032436T3 (es) Un procedimiento para la preparacion de un derivado de sulfoxido.
ES2155660T3 (es) Derivados de bencimidazol, de benzoxazol y de benzotiazol, utilizables como inhibidores de la interleuquina 1beta.
DK29285A (da) Methylendiphosphonsyrederivater og fremgangsmaade til fremstilling deraf samt antireumatiske farmaceutiske midler indeholdende derivaterne
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
ES2052522T3 (es) Derivados de pirimidina, su preparacion y medicamentos que los contienen.
ES2052526T3 (es) Derivados de pirimidina, su preparacion y medicamentos que contienen estos derivados.
ES2107578T3 (es) Inhibidores de la proteasa del vih del tipo isostero hidroxietilenico que contiene ditiolaniglicina.
AR246122A1 (es) Nuevos hidroxietil-azolil-derivados y procedimientos para su obtencion, intermediarios y composiciones fungicidas y reguladoras del crecimiento de plantas.
AR014119A1 (es) Utilizacion de cetolidas para la fabricacion de composiciones farmaceuticas destinadas a prevenir complicaciones tromboticas arteriales asociadas a laaterosclerosis
DK529388D0 (da) Zink-, bly-, og/eller calciumsalte af carboxylsyrer og anvendelse deraf som korrosionsbeskyttelsesmidler
ES2075137T3 (es) Compuestos sustituidos de piridina; su produccion y composiciones farmaceuticas que los contienen.
AR248276A1 (es) Derivados de imidazolidina, procedimiento para producirlos y pesticidas que los contienen
ATE67186T1 (de) 3-methylphthalimide.
ES2036583T3 (es) Iminooxazolidinas, procedimiento de preparacion y metodo de uso.
ES2135384T3 (es) Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.
ES2052206T3 (es) Procedimiento de preparacion de nuevos derivados de benzotiazolinona y las composiciones farmaceuticas que los contienen.
MX9303753A (es) Dihidropiridinas anilladas y composiciones farmaceuticas que las contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 257378

Country of ref document: ES